✦ LIBER ✦

A phase II trial of taxol in metastatic melanoma

✍ Scribed by Sewa S. Legha; Sigrid Ring; Nicholas Papadopoulos; Martin Raber; Robert S. Benjamin

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 321 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900601)65:11<2478::aid-cncr2820651114>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outpatient combination chemoimmunotherap

Outpatient combination chemoimmunotherapy for patients with metastatic melanoma : Results of a Phase I/II trial

✍ Mohammed Kashani-Sabet; Richard W. Sagebiel; Henry E. Collins; Alan B. Glassberg 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

## BACKGROUND. Few studies have examined the feasibility, safety, and efficacy of an outpatient biochemotherapy regimen of low dose, subcutaneously administered interleukin-2 (IL-2) for patients with metastatic (Stage IV) melanoma. ## METHODS. Nineteen patients were treated with intravenous cispl

Phase II trial of dimethyltriazenoimidaz

Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid

✍ Ronald M. Bukowski; Catherine M. Tangen; Robert F. Peterson; Thomas R. Fleming; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Background. The use of chemotherapy in patients with metastatic carcinoid tumors has been of limited value, and investigiition of new agents is necessary. Previous reports have suggested that dimethyltriazenoimidazole carboxamide (DTIC) may have antitumor activity. Methods. A Phase I1 trial to inve

Phase II trial of carboplatin and etopos

Phase II trial of carboplatin and etoposide in metastatic breast cancer

✍ John Crown; Thomas Hakes; Bonnie Reichman; David Lebwohl; Theresa Gilewski; Anto 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

## Background: High-dose chemotherapy with hematopoietic support produces high rates of response in metastatic breast cancer. to facilitate new high-dose regimens there is a need to identify active agents with toxicity limited to hematopoietic suppression. cisplatin/etoposide is a highly active reg

Clinical phase II trial of recombinant d

Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

✍ Thierry Dorval; Thao Palangie; Michel Jouve; Emilio Garcia-Giralt; Lucien Israel 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

Granulocyte-macrophage-colony stimulatin

Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma : A phase II trial

✍ Brian I. Rini; Walter M. Stadler; Ricardo T. Spielberger; Mark J. Ratain; Nichol 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## BACKGROUND. Due to lack of success with standard chemotherapy and only modest

A phase II trial of tamoxifen in hepatoc

A phase II trial of tamoxifen in hepatocellular carcinoma

✍ Paul F. Engstrom; Bernard Levin; Charles G. Moertel; Allan Schutt 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views